RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Changes in Psychotropic Prescription Patterns in Patients Admitted to an Open Psychiatric Ward : Eleven-Year Comparison in a University Hospital in Gyeonggi-Do

Korean J Biol Psychiatry 22(4):195-204 · 2015

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

766편 검색→716편 판독→169편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Changes in psychotropic drug prescription patterns among psychiatric inpatients over time (psychotropic*[tiab] OR "psychotropic drugs"[MeSH Terms] OR antipsychotic*[tiab] OR antidepressant*[tiab] OR "anti-anxiety agents"[MeSH Terms] OR "antipsychotic agents"[MeSH Terms] OR "antidepressive agents"[MeSH Terms]) AND (prescri*[tiab] OR "drug prescriptions"[MeSH Terms] OR "prescription drug misuse"[MeSH Terms] OR prescribing[tiab]) AND (inpatient*[tiab] OR hospitalized[tiab] OR "inpatients"[MeSH Terms] OR "psychiatric department, hospital"[MeSH Terms] OR "hospitalization"[MeSH Terms]) AND (trend*[tiab] OR change*[tiab] OR "over time"[tiab] OR longitudinal[tiab] OR "time factors"[MeSH Terms])

출판 연도

1979: 1편119791981: 2편21984: 1편119851986: 1편11987: 2편21988: 1편11990: 1편119901992: 1편11995: 1편119951997: 2편21998: 1편11999: 1편12000: 1편120002002: 4편42003: 5편52004: 3편32005: 5편520052006: 3편32007: 9편92008: 5편52009: 2편22010: 5편520102011: 9편92012: 8편82013: 4편42014: 4편42015: 12편1220152016: 6편62017: 3편32018: 5편52019: 5편52020: 4편420202021: 6편62022: 2편22023: 13편132024: 13편132025: 8편82026: 10편102026

선별된 169편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01drugs · antipsychotics88편

  1. 0.96

    Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998

    Citrome L, Levine J, Allingham B · Psychiatric services (Washington, D.C.) · 2000

  2. 0.96

    Change of psychotropic drug prescription for schizophrenia in a psychiatric institution in Beijing, China between 1999 and 2008

    An FR, Xiang YT, Wang CY et al. · International journal of clinical pharmacology and therapeutics · 2010

  3. 0.96

    Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004

    Centorrino F, Ventriglio A, Vincenti A et al. · Human psychopharmacology · 2010

  4. 0.95

    Trends in psychotropic drug use in a child psychiatric hospital from 1991-1998

    Najjar F, Welch C, Grapentine WL et al. · Journal of child and adolescent psychopharmacology · 2004

  5. 0.95

    Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program

    Konstantinidis A, Papageorgiou K, Grohmann R et al. · The international journal of neuropsychopharmacology · 2012

  6. 0.95

    Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study

    Grohmann R, Engel RR, Geissler KH et al. · Pharmacopsychiatry · 2004

  7. 0.95

    Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice

    Timaus C, Meiser M, Bandelow B et al. · BMC psychiatry · 2019

  8. 0.95

    Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study

    Toto S, Grohmann R, Bleich S et al. · The international journal of neuropsychopharmacology · 2019

  9. 0.94

    Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017

    Seifert J, Engel RR, Bernegger X et al. · Journal of affective disorders · 2021

  10. 0.94

    The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999

    Ungvari GS, Chung YG, Chee YK et al. · British journal of clinical pharmacology · 2002

  11. 0.94

    The use of (newer) antipsychotics in bipolar inpatients over a 17-year observation period

    Dehning J, Grunze H, Walpoth-Niederwanger M et al. · International clinical psychopharmacology · 2018

  12. 0.94

    Fourteen-year trends in prescribing patterns for patients with bipolar mania discharged from a public psychiatric hospital in Taiwan

    Chiu HP, Shih Y, Lin CH · Medicine · 2024

  13. 0.94

    Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016

    Greiner T, Haack B, Toto S et al. · European archives of psychiatry and clinical neuroscience · 2020

  14. 0.94

    Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison

    Barbui C, Ciuna A, Nose M et al. · European archives of psychiatry and clinical neuroscience · 2005

  15. 0.94

    Inpatient antipsychotic drug use in 1998, 1993, and 1989

    Centorrino F, Eakin M, Bahk WM et al. · The American journal of psychiatry · 2002

  16. 0.94

    Polypharmacy in patients with schizophrenia

    McCue RE, Waheed R, Urcuyo L · The Journal of clinical psychiatry · 2003

  17. 0.94

    Recent trends in prescribing psychotropic drugs at a psychiatric university hospital (1981-84)

    Schmidt LG, Lammers V, Stockel M et al. · Pharmacopsychiatry · 1988

  18. 0.93

    Changes in the treatment of acute psychosis in a German public hospital from 1998 to 2004

    Wessels T, Grunler D, Bunk C et al. · The Psychiatric quarterly · 2007

  19. 0.93

    Patterns of clinical use of antipsychotics in hospitalized psychiatric patients

    Mauri MC, Regispani F, Beraldo S et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2005

  20. 0.93

    Trends in Antipsychotic Drug Use in the United States, 2000-2016

    Haddad N, Farhat N, Go J et al. · Pharmacy (Basel, Switzerland) · 2026

  21. 0.93

    Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009)

    Xiang YT, Wang CY, Si TM et al. · Pharmacopsychiatry · 2012

  22. 0.93

    Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers

    Walpoth-Niederwanger M, Kemmler G, Grunze H et al. · International clinical psychopharmacology · 2012

  23. 0.93

    Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients

    Ventriglio A, Vincenti A, Centorrino F et al. · International clinical psychopharmacology · 2011

  24. 0.93

    Adjunctive mood stabilizer treatment for hospitalized schizophrenia patients: Asia psychotropic prescription study (2001-2008)

    Sim K, Yong KH, Chan YH et al. · The international journal of neuropsychopharmacology · 2011

  25. 0.93

    Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009

    Yoshio T, Inada T, Uno J et al. · Human psychopharmacology · 2012

  26. 0.93

    Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004

    Wolfsperger M, Greil W, Rossler W et al. · Journal of affective disorders · 2007

  27. 0.93

    Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade

    Arikan MK, Poyraz CA, Bas A et al. · The Psychiatric quarterly · 2016

  28. 0.93

    Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009

    Greil W, Haberle A, Haueis P et al. · Journal of affective disorders · 2012

  29. 0.92

    Adjunctive antidepressant prescriptions for hospitalized patients with schizophrenia in Asia (2001-2009)

    Xiang YT, Ungvari GS, Wang CY et al. · Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists · 2013

  30. 0.92

    Psychopharmacological treatment of 1650 in-patients with acute mania-data from the AMSP study

    Kleimann A, Schrader V, Stubner S et al. · Journal of affective disorders · 2016

  31. 0.92

    Prescribing patterns for older-age bipolar disorder patients discharged from two public mental hospitals in Taiwan, 2006-2019

    Lin CH, Hsu CC, Chan HY et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2024

  32. 0.92

    Twenty-four years of prescription patterns in bipolar disorder inpatients with vs without lithium: a pharmacoepidemiological analysis of 8,707 cases in German-speaking countries

    Greil W, de Bardeci M, Nievergelt N et al. · International journal of bipolar disorders · 2025

  33. 0.92

    Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison

    Roh D, Chang JG, Kim CH et al. · The Australian and New Zealand journal of psychiatry · 2014

  34. 0.92

    Utilization of valproate: extent of inpatient use in the New York State Office of Mental Health

    Citrome L, Levine J, Allingham B · The Psychiatric quarterly · 1998

  35. 0.91

    Antipsychotic drug use: McLean Hospital, 2002

    Centorrino F, Fogarty KV, Sani G et al. · Human psychopharmacology · 2005

  36. 0.91

    The impact of a change in prescribing policy on antipsychotic prescribing in a general adult psychiatric hospital

    Kelly J, Kelly F, Santlal K et al. · Irish journal of psychological medicine · 2014

  37. 0.91

    Psychotropic drug prescription in a psychiatric university hospital in Germany

    Davids E, Bunk C, Specka M et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2006

  38. 0.90

    Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme

    Mace S, Taylor D · Therapeutic advances in psychopharmacology · 2015

  39. 0.89

    Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011

    Holl AK, Grohmann R, Letmaier M et al. · European archives of psychiatry and clinical neuroscience · 2015

  40. 0.89

    Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries

    Reinhard MA, Seifert J, Greiner T et al. · European archives of psychiatry and clinical neuroscience · 2021

  41. 0.89

    Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital

    Wu YH, Lai CY, Chang YS · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2015

  42. 0.89

    Quetiapine indication shift in the elderly: diagnosis and dosage in 208 psychogeriatric patients from 2000 to 2006

    Hilwerling L, Juckel G, Schroder SG · International journal of geriatric psychiatry · 2007

  43. 0.88

    Real-World treatment patterns in inpatients with newly diagnosed bipolar disorder in China: A descriptive longitudinal study

    Yu H, Xu N, Yang R et al. · Journal of affective disorders · 2026

  44. 0.88

    Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012

    Poppe C, Muller ST, Greil W et al. · Journal of affective disorders · 2016

  45. 0.87

    Effectiveness of medical fee revisions for psychotropic polypharmacy in patients with mood disorders in Japan: An interrupted time-series analysis using a nationwide inpatient database

    Yamazaki R, Ohbe H, Matsuda Y et al. · Asian journal of psychiatry · 2023

  46. 0.86

    Comorbidity and Treatment in Older Psychiatric In-patients-A Retrospective Study in a Chinese Psychiatric Hospital

    Liu H, Zhu Y, Wu X et al. · Frontiers in psychiatry · 2021

  47. 0.86

    Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008

    Tor PC, Ng TP, Yong KH et al. · The international journal of neuropsychopharmacology · 2011

  48. 0.86

    Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project

    Hashimoto N, Yasui-Furukori N, Hasegawa N et al. · BMC psychiatry · 2023

  49. 0.83

    Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008

    Haueis P, Russmann S, Zorina OI et al. · Pharmacopsychiatry · 2012

  50. 0.83

    Implementation of a schizophrenia practice guideline: clinical results

    Weinmann S, Hoerger S, Erath M et al. · The Journal of clinical psychiatry · 2008

  51. 0.81

    Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019

    Lin CH, Chan HY, Chen CC et al. · Journal of affective disorders · 2022

  52. 0.81

    Antipsychotic treatment patterns and predictors of polypharmacy in psychotic disorders: 20-year real-world data from a tertiary center

    Dagdemir E, Ceyhun HA, Okutucu FT · Irish journal of medical science · 2026

  53. 0.80

    Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017

    Seifert J, Fuhrmann F, Reinhard MA et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2021

  54. 0.80

    Pharmacological treatment of late-life major depressive disorder - Results from the AMSP drug surveillance program from 2007 to 2023

    Schulze Westhoff M, Toto S, Bleich S et al. · Journal of affective disorders · 2026

  55. 0.80

    Integration of a psychiatric service in a long-term charitable facility for people with intellectual disabilities: a 5-year medication survey

    Ruggerini C, Guaraldi GP, Russo A et al. · Research in developmental disabilities · 2004

  56. 0.78

    Pharmacoepidemiologic Trends and Factors Associated With Use and Dosing of Newer Antidepressants in 8357 Patients Across Asia: A Two-Decade Perspective

    Ying J, Chew QH, Si TM et al. · Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists · 2026

  57. 0.75

    Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders

    Bridler R, Haberle A, Muller ST et al. · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2015

  58. 0.75

    Longitudinal assessment of psychotropic drug use in acutely-ill psychiatric inpatients

    Schmidt LG, Czerlinsky H, Stockel M · International journal of clinical pharmacology, therapy, and toxicology · 1987

  59. 0.75

    Prescribing and deprescribing of atypical antipsychotics in older multimorbid patients

    Schneider C, O'Mahony D, Byrne S et al. · BMC geriatrics · 2025

  60. 0.75

    Patterns of drug prescribing in inpatients with first episode of schizophrenia spectrum disorder: The role of guidelines


    Stasevic M, Stasevic Karlicic I, Grgurevic A et al. · International journal of clinical pharmacology and therapeutics · 2020

  61. 0.74

    Benzodiazepine Prescribing in Delirium Diagnosis: National Data on Clinical Practice

    Kalyoncu A, Mormando C, Francis A · Journal of the Academy of Consultation-Liaison Psychiatry · 2026

  62. 0.74

    Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility

    Saklad SR, Ereshefsky L, Jann MW et al. · Drug intelligence & clinical pharmacy · 1984

  63. 0.74

    Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study

    Grohmann R, Engel RR, Moller HJ et al. · European archives of psychiatry and clinical neuroscience · 2014

  64. 0.72

    Simulated discharge system of prescription and long-term drug treatment in a psychiatric hospital

    Ballinger BR · Acta psychiatrica Scandinavica · 1979

  65. 0.72

    Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study

    Zerbinati L, Palagini L, Balestrieri M et al. · Frontiers in psychiatry · 2022

  66. 0.72

    Factors Associated With Antidepressant Dosing in Asia: Findings From the Research on Asian Psychotropic Prescription Study

    Rajaratnam K, Xiang YT, Tripathi A et al. · Journal of clinical psychopharmacology · 2016

  67. 0.70

    Antipsychotic utilisation and polypharmacy in Italian residential facilities: a survey

    Ghio L, Natta W, Gotelli S et al. · Epidemiology and psychiatric sciences · 2011

  68. 0.69

    Fourteen-year trends in the prescribing patterns of pediatric bipolar patients discharged from two public mental hospitals in Taiwan

    Lin CH, Chan HY, Lin HY et al. · Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists · 2023

  69. 0.69

    Antipsychotic polypharmacy among patients admitted to a geriatric psychiatry unit

    Dolder CR, McKinsey J · Journal of psychiatric practice · 2011

  70. 0.69

    Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia: A Pre-Post Comparison Using Electronic Health Records

    Lagreula J, Ferraiolo M, De Timary P et al. · Journal of clinical psychopharmacology · 2023

  71. 0.67

    A retrospective study of psychotropic drug treatments in bipolar disorder at acute and maintenance episodes

    Jing P, Su J, Zheng C et al. · Frontiers in psychiatry · 2023

  72. 0.66

    Pharmacotherapy for schizophrenic inpatients in East Asia--changes and challenges

    Shinfuku N, Tan CH · International review of psychiatry (Abingdon, England) · 2008

  73. 0.66

    Original research paper. Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders

    Bole CB, Pislar M, Sen M et al. · Acta pharmaceutica (Zagreb, Croatia) · 2017

  74. 0.64

    Social aspects of therapy with depot neuroleptics in the Federal Republic of Germany

    Haring C, Tegeler J, Lehmann E et al. · Acta psychiatrica Belgica · 1981

  75. 0.64

    Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community

    Thinn K, Clarke DJ, Corbett JA · Journal of mental deficiency research · 1990

  76. 0.64

    Use of electroconvulsive therapy for Asian patients with schizophrenia (2001-2009): Trends and correlates

    Xiang YT, Ungvari GS, Correll CU et al. · Psychiatry and clinical neurosciences · 2015

  77. 0.62

    Consultation-liaison psychiatry: stability and change over a 10-year-period

    Diefenbacher A, Strain JJ · General hospital psychiatry · 2002

  78. 0.62

    A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia

    Taylor D, Hayhurst K, Kerwin R · International clinical psychopharmacology · 2007

  79. 0.62

    Long-term use of benzodiazepines in psychiatric inpatients

    Laux G, Konig W · Acta psychiatrica Scandinavica · 1987

  80. 0.59

    Antipsychotic Polypharmacy in Time Course: Evidence for a Cross-titration Trap

    Lochmann van Bennekom MWH, Gijsman HJ, IntHout J et al. · Journal of clinical psychopharmacology · 2024

  81. 0.57

    Anxiolytic and hypnotic use in 376 psychiatric inpatients. GERMED Neuropsychotropics Group

    Hardy P, Payan C, Bisserbe JC et al. · European psychiatry : the journal of the Association of European Psychiatrists · 1999

  82. 0.57

    QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009

    Xiang YT, Chiu HFK, Ungvari GS et al. · Human psychopharmacology · 2015

  83. 0.56

    Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia

    Rothbard AB, Kuno E, Foley K · Schizophrenia bulletin · 2003

  84. 0.56

    Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders

    Vincenti A, Ventriglio A, Baldessarini RJ et al. · Pharmacopsychiatry · 2010

  85. 0.55

    Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelines

    Stein M, Dietrich DE, Agelink MW et al. · Pharmacopsychiatry · 2012

  86. 0.52

    Prescribing and deprescribing trends in schizophrenia: An overview of inpatients in Belgium and in the Canadian province of Quebec

    Lagreula J, Dagenais-Beaule V, de Timary P et al. · Basic & clinical pharmacology & toxicology · 2023

  87. 0.51

    Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies

    Citrome L, Jaffe A, Levine J et al. · The Journal of clinical psychiatry · 2005

  88. 0.50

    Tardive dyskinesia in the treatment of schizophrenia: the findings of the Research on Asian Psychotropic Prescription Pattern (REAP) survey (2001 - 2009)

    Xiang YT, Wang CY, Si TM et al. · International journal of clinical pharmacology and therapeutics · 2011

02depression · antidepressant24편

  1. 0.88

    A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study

    Tada T, Suzuki T, Iwata Y et al. · Pharmacopsychiatry · 2024

  2. 0.88

    Reduction of benztropine use duration in acute psychiatry: A quality improvement initiative

    Seals W, Holder MP, Polancich S et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2024

  3. 0.87

    Development and delivery of a quality improvement program to reduce antipsychotic polytherapy

    Goren JL, Beck SE, Mills BJ et al. · Journal of managed care pharmacy : JMCP · 2010

  4. 0.86

    High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing

    Paton C, Barnes TRE, Cavanagh MR et al. · The British journal of psychiatry : the journal of mental science · 2008

  5. 0.84

    Prescribing trends of antidepressants in bipolar depression

    Zarate CAJ, Tohen M, Baraibar G et al. · The Journal of clinical psychiatry · 1995

  6. 0.82

    The use of benzodiazepine monotherapy for major depression before and after implementation of guidelines for benzodiazepine use

    Lai IC, Wang MT, Wu BJ et al. · Journal of clinical pharmacy and therapeutics · 2011

  7. 0.82

    Changing prescribing practice for rapid tranquillization-a quality improvement project based on the Plan-Do-Study-Act method

    Baandrup L, Dons AM, Bartholdy KV et al. · Social psychiatry and psychiatric epidemiology · 2024

  8. 0.73

    No benefit of antidepressants in inpatient treatment of depression. A longitudinal, quasi-experimental field study

    Mass R, Backhaus K, Lohrer K et al. · Psychopharmacology · 2023

  9. 0.73

    Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study

    Saito Y, Sumida K, Muraoka H et al. · BMC psychiatry · 2025

  10. 0.72

    Consultation-liaison psychiatrists' use of antidepressants in the physically ill

    Smith GC, Clarke DM, Handrinos D et al. · Psychosomatics · 2002

  11. 0.70

    The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial

    Thompson A, Sullivan SA, Barley M et al. · Psychological medicine · 2008

  12. 0.70

    Impact of multi-professional medication reviews (MPMRs) on medication prescriptions in psychiatry

    Lebrat M, Cohen A, Megard R et al. · PloS one · 2026

  13. 0.62

    Prescribing trends in veterans with posttraumatic stress disorder

    Bernardy NC, Lund BC, Alexander B et al. · The Journal of clinical psychiatry · 2012

  14. 0.61

    Psychotropic Polypharmacy and QT Prolonging Medications in Hospitalized Patients

    Moore J, Singh I, Au RT et al. · Pharmacology research & perspectives · 2025

  15. 0.60

    P.R.N. (As-needed) orders and exposure of psychiatric inpatients to unnecessary psychotropic medications

    Thapa PB, Palmer SL, Owen RR et al. · Psychiatric services (Washington, D.C.) · 2003

  16. 0.60

    Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center

    Dobscha SK, Anderson TA, Hoffman WF et al. · Psychiatric services (Washington, D.C.) · 2003

  17. 0.60

    Examining trends in the administration of "as needed" medications to inpatients with behavioral and psychological symptoms of dementia

    Neumann RD, Faris P, Klassen R · American journal of Alzheimer's disease and other dementias · 2015

  18. 0.60

    Improving the quality and reliability of clinical reviews of psychotropic PRN medicines in a large English mental health Trust

    Innes J, Ugochukwu U, Trenholm J et al. · BMJ open quality · 2025

  19. 0.60

    Antipsychotic, benzodiazepine and Z-drug prescriptions in a Swiss hospital network in the Choosing Wisely and COVID-19 eras: a longitudinal study

    Gagliano V, Salemme G, Ceschi A et al. · Swiss medical weekly · 2024

  20. 0.58

    Pharmacotherapy and electroconvulsive therapy prescription for women with depressive and anxiety disorders in a psychiatric mother-baby unit

    Saluja S, Cooter A, Roberts S et al. · Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · 2024

  21. 0.54

    Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial

    Suzuki H, Gen K · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2015

  22. 0.52

    Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression

    Rutz W, von Knorring L, Walinder J · Acta psychiatrica Scandinavica · 1992

  23. 0.51

    Combining prescription monitoring, benchmarking, and educational interventions to reduce benzodiazepine prescriptions among internal medicine inpatients; a multicenter before and after study in a network of Swiss Public Hospitals

    Del Giorno R, Greco A, Zasa A et al. · Postgraduate medicine · 2018

  24. 0.51

    Use of a Novel Standardized Administration Protocol Reduces Agitation Pro Re Nata (PRN) Medication Requirements: The Birmingham Agitation Management (BAM) Initiative

    Burk BG, Penherski P, Snider K et al. · The Annals of pharmacotherapy · 2023

03hospital · drugs13편

  1. 0.90

    Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry

    Do A, Noohi S, Elie D et al. · Psychosomatics · 2016

  2. 0.90

    Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing

    McIlroy G, Thomas SK, Coleman JJ · Journal of public health (Oxford, England) · 2015

  3. 0.83

    Moving to a purpose built acute psychiatric unit on a general hospital site--does the new environment produce change for the better?

    Feeney L, Kavanagh A, Kelly BD et al. · Irish medical journal · 2007

  4. 0.77

    Trends in registered psychiatric morbidity and forecasting psychotropic drug needs in Bulgarian hospitals

    Dimitrova Dimitrova Z, Dumanov VG, Ivanova Petrova G · Acta pharmaceutica Hungarica · 1997

  5. 0.74

    The antipsychotic story: changes in prescriptions and overdose without better safety

    Berling I, Buckley NA, Isbister GK · British journal of clinical pharmacology · 2016

  6. 0.74

    Trends in Delirium and New Antipsychotic and Benzodiazepine Use Among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic

    Reppas-Rindlisbacher C, Boblitz A, Fowler RA et al. · JAMA network open · 2023

  7. 0.65

    Trends in psychotropic prescribing in general practice and general medical patients

    Smith AR, McIntosh M, McInnes GT et al. · Postgraduate medical journal · 1986

  8. 0.64

    Depot neuroleptics : a Scandinavian view

    Dencker SJ · Acta psychiatrica Belgica · 1981

  9. 0.58

    Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications

    Reinold J, Palese F, Romanese F et al. · International journal of geriatric psychiatry · 2019

  10. 0.53

    Longitudinal Trends and Variation in Antipsychotic Use in Older Adults After Cardiac Surgery

    Kim DH, Mahesri M, Bateman BT et al. · Journal of the American Geriatrics Society · 2018

  11. 0.51

    Impact of legislative changes on patterns of antipsychotic prescribing and self-poisoning in Scotland: 2000-06

    Poon H, Elliot V, Bateman DN et al. · The Journal of toxicological sciences · 2007

  12. 0.51

    Changing trends in hospitalization rates associated with psychosis: Spain, 1980-2009

    Medel-Herrero A, Amate JM, Saz-Parkinson Z et al. · Social psychiatry and psychiatric epidemiology · 2015

  13. 0.51

    Effects of licence change on prescribing and poisons enquiries for antipsychotic agents in England and Scotland

    Bateman DN, Good AM, Afshari R et al. · British journal of clinical pharmacology · 2003

04clozapine · dose12편

  1. 0.95

    Changes in psychopharmacotherapy for patients with schizophrenia in a psychiatric institution in Japan: A 12-year prescription survey pre- and post-introduction of clozapine

    Kitagawa K, Uekusa S, Hanai Y et al. · Asian journal of psychiatry · 2024

  2. 0.94

    Trends in the prescription of clozapine in a psychiatric hospital: a 5-year observational study

    Niehues GD, Balan AB, Pra VB et al. · Trends in psychiatry and psychotherapy · 2017

  3. 0.93

    Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021

    Lin CH, Huang CJ, Lin TC et al. · Psychiatry research · 2023

  4. 0.90

    Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009

    Xiang YT, Wang CY, Si TM et al. · The Australian and New Zealand journal of psychiatry · 2011

  5. 0.81

    Schizophrenia Patients Discharged on Clozapine Plus Long-Acting Injectable Antipsychotics From a Public Psychiatric Hospital in Taiwan, 2006-2021

    Lin TC, Lin CH · The international journal of neuropsychopharmacology · 2023

  6. 0.80

    Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)

    Li Q, Xiang YT, Su YA et al. · Schizophrenia research · 2015

  7. 0.80

    Use of clozapine in older Asian patients with schizophrenia between 2001 and 2009

    Xiang YT, Buchanan RW, Ungvari GS et al. · PloS one · 2013

  8. 0.78

    The factors associated with clozapine polypharmacy for schizophrenia patients discharged from a large public psychiatric hospital in Taiwan, 2006-2021

    Shih YJ, Lin CH, Chou LS · Medicine · 2024

  9. 0.74

    Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis

    Lee LHN, Procyshyn RM, White RF et al. · PloS one · 2018

  10. 0.53

    Clozapine use - has practice changed?

    Rowntree R, Murray S, Fanning F et al. · Journal of psychopharmacology (Oxford, England) · 2020

  11. 0.52

    Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment

    Modestin J, Wehrli MV, Stephan PL et al. · Schizophrenia research · 2008

  12. 0.52

    Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial

    Hansen HG, Speyer H, Sturup AE et al. · Psychological medicine · 2024

05children · adolescents12편

  1. 0.94

    Trends in prescribing of psychotropic medications for inpatient adolescents in Israel: a 10 years retrospective analysis

    Gilat Y, Ben-Dor DH, Magen A et al. · European psychiatry : the journal of the Association of European Psychiatrists · 2011

  2. 0.94

    Changing trends in inpatient care for psychiatrically hospitalized youth: 1991-2008

    Meagher SM, Rajan A, Wyshak G et al. · The Psychiatric quarterly · 2013

  3. 0.93

    Trends in the prescribing of psychotropic medications for inpatient children and adolescents, 2000-2010: a study from China

    Song QY, Guo LT · International clinical psychopharmacology · 2013

  4. 0.93

    Psychotropic prescribing trends in a Peruvian General Hospital during and after the COVID-19 pandemic: an interrupted time-series analysis

    Salvador-Carrillo J, Figueiredo-Modesto AC, Cruz-Lopes L et al. · Frontiers in public health · 2026

  5. 0.83

    Predictors and Correlates of Psychiatric Polypharmacy Among Child and Adolescent Psychiatric Inpatients: A Retrospective Study

    Lynch S, Becker T, Shanker P et al. · Journal of clinical psychopharmacology · 2025

  6. 0.77

    Changing patterns of psychotropic medications prescribed by child psychiatrists in the 1990s

    Safer DJ · Journal of child and adolescent psychopharmacology · 1997

  7. 0.68

    Impact of the emotional development approach on psychotropic medication in adults with intellectual and developmental disabilities: a retrospective clinical analysis

    Barrett BF, Wehmeyer M, Kolb J et al. · Journal of intellectual disability research : JIDR · 2024

  8. 0.64

    Racial and ethnic disparities in the treatment of a Medicaid population with schizophrenia

    Horvitz-Lennon M, McGuire TG, Alegria M et al. · Health services research · 2009

  9. 0.63

    Initiation and change of psychotropic medication regimens among adolescents in inpatient care

    Warner LA, Fontanella CA, Pottick KJ · Journal of child and adolescent psychopharmacology · 2007

  10. 0.60

    Trends in Mental Health Care Use in Medicare from 2009 to 2014 by Gender Minority and Disability Status

    Progovac AM, Mullin BO, Creedon TB et al. · LGBT health · 2019

  11. 0.53

    Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study

    McIntyre RS, Jerrell JM · The Journal of clinical psychiatry · 2009

  12. 0.53

    A Pilot Evaluation of Dialectical Behavioural Therapy in Adolescent Long-Term Inpatient Care

    McDonell MG, Tarantino J, Dubose AP et al. · Child and adolescent mental health · 2010

06oral · long-acting10편

  1. 0.90

    Inpatient prescribing patterns of long-acting injectables and their oral or short-acting injectable equivalent formulations

    Liu Y, Patterson ME, Sahil S et al. · Frontiers in pharmacology · 2023

  2. 0.87

    Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics

    Lin CH, Chan HY, Hsu CC et al. · Journal of affective disorders · 2021

  3. 0.82

    Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics

    Lin CH, Chen FC, Chan HY et al. · The international journal of neuropsychopharmacology · 2019

  4. 0.77

    A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia

    Lin CH, Chen FC, Chan HY et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2020

  5. 0.67

    Real-world antipsychotic prescribing pathways and treatment modifications in schizophrenia spectrum disorders: evidence from the United Arab Emirates

    Bokhari SA, Elnoor M, Javaid SF et al. · Frontiers in pharmacology · 2026

  6. 0.63

    Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study

    Ostuzzi G, Tedeschi F, Bertolini F et al. · Schizophrenia (Heidelberg, Germany) · 2023

  7. 0.62

    Real-World Prescribing Patterns of Long-Acting Injectable Antipsychotics in Australian Psychiatric Inpatients: Trends, Clinical Outcomes, and Substance Use Prevalence

    Akindele T, De Alwis K · Drugs - real world outcomes · 2025

  8. 0.62

    Retrospective cohort study of long-acting injectable (LAI) antipsychotic initiation in the inpatient setting: impact of LAI characteristics on transition and continuation of care among patients with schizophrenia in the USA

    Patel R, Liman C, Oyesanya M et al. · BMJ open · 2025

  9. 0.52

    Health resource utilization associated with switching to risperidone long-acting injection

    Young CL, Taylor DM · Acta psychiatrica Scandinavica · 2006

  10. 0.50

    Haloperidol decanoate long-acting injection (HDLAI): Results of a 1-year mirror-image study

    Mace S, Dzahini O, O'Hagan M et al. · Therapeutic advances in psychopharmacology · 2018

07utilization · visits5편

  1. 0.86

    Trends in psychotropic use among older adults with dementia in Korean long-term care hospitals across the COVID-19 pandemic: a national longitudinal study

    Kim E, Yoon JM, Trinkoff AM · Frontiers in public health · 2026

  2. 0.81

    Off-Label Prescribing of Second-Generation Antipsychotics to Elderly Veterans with Posttraumatic Stress Disorder and Dementia

    Semla TP, Lee A, Gurrera R et al. · Journal of the American Geriatrics Society · 2017

  3. 0.72

    Usage and cost of first-line drugs for patients referred to inpatient anthroposophic integrative care or inpatient conventional care for stress-related mental disorders--a register based study

    Sundberg T, Hussain-Alkhateeb L, Falkenberg T · BMC complementary and alternative medicine · 2015

  4. 0.59

    Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004

    Gilmer TP, Dolder CR, Folsom DP et al. · Psychiatric services (Washington, D.C.) · 2007

  5. 0.55

    Effect of a medication copayment increase in veterans with schizophrenia

    Zeber JE, Grazier KL, Valenstein M et al. · The American journal of managed care · 2007

08olanzapine · antipsychotic5편

  1. 0.83

    Risperidone: an open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia

    Pajonk FG, Schreiner A, Peters S et al. · Journal of clinical psychopharmacology · 2005

  2. 0.73

    Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study

    Strous RD, Bar F, Keret N et al. · The Israel journal of psychiatry and related sciences · 2006

  3. 0.70

    Analysis of the status of drug treatment in 746 inpatients with early-onset schizophrenia in China: a retrospective study

    Zhang J, Cheng X, Zhang H et al. · BMC psychiatry · 2021

  4. 0.59

    Trajectories of daily antipsychotic use and weight gain in people hospitalized for the first episode of psychosis

    Vochoskova K, McWhinney SR, Fialova M et al. · European psychiatry : the journal of the Association of European Psychiatrists · 2024

  5. 0.58

    Do prior authorization policies discourage first-line antipsychotic use in patients newly discharged from a hospitalization for schizophrenia in Saskatchewan?

    Blackburn DF, Tran D, Crawley A et al. · Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique · 2014